168 related articles for article (PubMed ID: 35935983)
1. Immunological risk factors for nonalcoholic fatty liver disease in patients with psoriatic arthritis: New predictive nomograms and natural killer cells.
Li B; Su R; Yan H; Liu J; Gao C; Li X; Wang C
Front Immunol; 2022; 13():907729. PubMed ID: 35935983
[TBL] [Abstract][Full Text] [Related]
2. Serum Lipid Abnormalities and Nonalcoholic Fatty Liver Disease in Adult Males.
Peng K; Mo Z; Tian G
Am J Med Sci; 2017 Mar; 353(3):236-241. PubMed ID: 28262209
[TBL] [Abstract][Full Text] [Related]
3. A nomogram for estimating the probability of nonalcoholic fatty liver disease in a Chinese population: A retrospective cohort study.
Xie W; Chen S
Medicine (Baltimore); 2020 Nov; 99(48):e23049. PubMed ID: 33235066
[TBL] [Abstract][Full Text] [Related]
4. Metabolic syndrome, non-alcoholic fatty liver disease and liver stiffness in psoriatic arthritis and psoriasis patients.
Ortolan A; Lorenzin M; Tadiotto G; Russo FP; Oliviero F; Felicetti M; D'Incà R; Favero M; Piaserico S; Doria A; Ramonda R
Clin Rheumatol; 2019 Oct; 38(10):2843-2850. PubMed ID: 31254236
[TBL] [Abstract][Full Text] [Related]
5. A clinical and laboratory-based nomogram for predicting nonalcoholic fatty liver disease in non-diabetic adults: a cross-sectional study.
Qian Y; Sun B; Zhang Y; Zhang M; Jiao X; Lai L; Yang W
Ann Palliat Med; 2022 Jul; 11(7):2349-2359. PubMed ID: 35542976
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a clinical and laboratory-based nomogram to predict nonalcoholic fatty liver disease.
Cen C; Wang W; Yu S; Tang X; Liu J; Liu Y; Zhou L; Yu J; Zheng S
Hepatol Int; 2020 Sep; 14(5):808-816. PubMed ID: 32572817
[TBL] [Abstract][Full Text] [Related]
7. [Value of constructing a non-invasive diagnostic model based on serum heme oxygenase-1 and glucose regulatory protein 78 for non-alcoholic fatty liver disease].
Cao JC; Zhang HK; Liu CM; Zhao SS; Nan YM; Li DD
Zhonghua Gan Zang Bing Za Zhi; 2024 Mar; 32(3):228-234. PubMed ID: 38584104
[No Abstract] [Full Text] [Related]
8. Predicting the Risk of Psoriatic Arthritis in Plaque Psoriasis Patients: Development and Assessment of a New Predictive Nomogram.
Liu P; Kuang Y; Ye L; Peng C; Chen W; Shen M; Zhang M; Zhu W; Lv C; Chen X
Front Immunol; 2021; 12():740968. PubMed ID: 35126345
[TBL] [Abstract][Full Text] [Related]
9. Dyslipidemia is associated with pediatric nonalcoholic fatty liver disease.
Dowla S; Aslibekyan S; Goss A; Fontaine K; Ashraf AP
J Clin Lipidol; 2018; 12(4):981-987. PubMed ID: 29699915
[TBL] [Abstract][Full Text] [Related]
10. A Nomogram Model Based on Noninvasive Bioindicators to Predict 3-Year Risk of Nonalcoholic Fatty Liver in Nonobese Mainland Chinese: A Prospective Cohort Study.
Cai X; Aierken X; Ahmat A; Cao Y; Zhu Q; Wu T; Li N
Biomed Res Int; 2020; 2020():8852198. PubMed ID: 33204721
[TBL] [Abstract][Full Text] [Related]
11. A nomogram incorporated lifestyle indicators for predicting nonalcoholic fatty liver disease.
Peng K; Wang S; Gao L; You H
Medicine (Baltimore); 2021 Jul; 100(26):e26415. PubMed ID: 34190160
[TBL] [Abstract][Full Text] [Related]
12. Nomogram for predicting the risk of nonalcoholic fatty liver disease in older adults in Qingdao, China: A cross-sectional study.
Wang Z; Cui J; Li X; Gao R; Feng E; Luo G; Guo B; Wu H; Sun Y; Sun J
Asia Pac J Clin Nutr; 2024 Mar; 33(1):83-93. PubMed ID: 38494690
[TBL] [Abstract][Full Text] [Related]
13. A nomogram for discrimination of non-alcoholic fatty liver disease in patients with chronic hepatitis B.
Chen Y; Cao D; Li C; Zhang P; Wang X; Li N; Han Q; Liu Z
Eur J Gastroenterol Hepatol; 2021 Jan; 33(1):69-75. PubMed ID: 32118853
[TBL] [Abstract][Full Text] [Related]
14. SFI, a sex hormone binding globulin based nomogram for predicting non-alcoholic fatty liver disease in the Chinese population.
Hua X; Zhang H; Yang W; Liu G; Zhang S; Wang Y
Front Endocrinol (Lausanne); 2023; 14():1176019. PubMed ID: 37334312
[TBL] [Abstract][Full Text] [Related]
15. Nomogram for Quantitatively Estimating the Risk of Fibrosis Progression in Type 2 Diabetic Patients With Nonalcoholic Fatty Liver Disease: A Pilot Study.
Xia J; Jin G; Hua Q; Cui S; Li J
Front Endocrinol (Lausanne); 2022; 13():917304. PubMed ID: 35837300
[TBL] [Abstract][Full Text] [Related]
16. Total cholesterol to high-density lipoprotein cholesterol ratio is a significant predictor of nonalcoholic fatty liver: Jinchang cohort study.
Ren XY; Shi D; Ding J; Cheng ZY; Li HY; Li JS; Pu HQ; Yang AM; He CL; Zhang JP; Ma YB; Zhang YW; Zheng TZ; Bai YN; Cheng N
Lipids Health Dis; 2019 Feb; 18(1):47. PubMed ID: 30744645
[TBL] [Abstract][Full Text] [Related]
17. A correlation study of the relationships between nonalcoholic fatty liver disease and serum triglyceride concentration after an oral fat tolerance test.
Hou X; Guan Y; Tang Y; Song A; Zhao J; Ren L; Chen S; Wei L; Ma H; Song G
Lipids Health Dis; 2021 May; 20(1):54. PubMed ID: 34034748
[TBL] [Abstract][Full Text] [Related]
18. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of an online dynamic nomogram based on the atherogenic index of plasma to screen nonalcoholic fatty liver disease.
Peng H; Zhang J; Huang X; Xu M; Huang J; Wu Y; Peng XE
Lipids Health Dis; 2023 Mar; 22(1):44. PubMed ID: 36991386
[TBL] [Abstract][Full Text] [Related]
20. Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLD.
Bril F; Sninsky JJ; Baca AM; Superko HR; Portillo Sanchez P; Biernacki D; Maximos M; Lomonaco R; Orsak B; Suman A; Weber MH; McPhaul MJ; Cusi K
J Clin Endocrinol Metab; 2016 Feb; 101(2):644-52. PubMed ID: 26672634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
